@article{cd7b5651cd264d6c8142678c3ee6a829,
title = "Time to Uveitis Control with Methotrexate and Mycophenolate Mofetil",
keywords = "Corticosteroid, Methotrexate, Mycophenolate mofetil, Uveitis",
author = "{First-Line Antimetabolites as Steroid-Sparing Treatment Research Group} and Bui, {Anh D.} and Kong, {Christina L.} and Kelly, {Nicole K.} and Rathinam, {S. R.} and Gonzales, {John A.} and Radhika Thundikandy and Anuradha Kanakath and Bala Murugan and R. Vedhanayaki and Lim, {Lyndell L.} and Suhler, {Eric B.} and Al-Dhibi, {Hassan A.} and Thuy Doan and Acharya, {Nisha R.}",
note = "Funding Information: Supported by the National Eye Institute, National Institutes of Health, Bethesda, Maryland (grant nos.: U10 EY021125 [N.R.A.] and EY06190 [Department of Ophthalmology, University of California, San Francisco]); Research to Prevent Blindness Foundation, New York, New York (unrestricted grant to the Department of Ophthalmology, University of California, San Francisco); and That Man May See Foundation (Department of Ophthalmology, University of California, San Francisco). ",
year = "2022",
month = jun,
doi = "10.1016/j.ophtha.2022.01.020",
language = "English (US)",
volume = "129",
pages = "721--723",
journal = "Ophthalmology",
issn = "0161-6420",
publisher = "Elsevier Inc.",
number = "6",
}